Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana.
Legrand E, Yrinesi J, Ekala MT, Péneau J, Volney B, Berger F, Bouchier C, Bertani S, Musset L, Meynard JB, Mercereau-Puijalon O.
Antimicrob Agents Chemother. 2012 Mar;56(3):1382-9. Epub 2012 Jan 9.
Related citations
Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani.
Purkait B, Kumar A, Nandi N, Sardar AH, Das S, Kumar S, Pandey K, Ravidas V, Kumar M, De T, Singh D, Das P.
Antimicrob Agents Chemother. 2012 Feb;56(2):1031-41. Epub 2011 Nov 28.
Baseline in vitro activities of the antimalarials pyronaridine and methylene blue against Plasmodium falciparum isolates from Kenya.
Okombo J, Kiara SM, Mwai L, Pole L, Ohuma E, Ochola LI, Nzila A.
Antimicrob Agents Chemother. 2012 Feb;56(2):1105-7. Epub 2011 Nov 28.
Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivo.
Erfe MC, David CV, Huang C, Lu V, Maretti-Mira AC, Haskell J, Bruhn KW, Yeaman MR, Craft N.
Antimicrob Agents Chemother. 2012 Feb;56(2):658-65. Epub 2011 Nov 28.
In vivo activity of aryl ozonides against Schistosoma species.
Keiser J, Ingram K, Vargas M, Chollet J, Wang X, Dong Y, Vennerstrom JL.
Antimicrob Agents Chemother. 2012 Feb;56(2):1090-2. Epub 2011 Nov 21.
Phenotypic and genotypic analysis of in vitro-selected artemisinin-resistant progeny of Plasmodium falciparum.
Tucker MS, Mutka T, Sparks K, Patel J, Kyle DE.
Antimicrob Agents Chemother. 2012 Jan;56(1):302-14. Epub 2011 Nov 14.
Downregulation of mitogen-activated protein kinase 1 of Leishmania donovani field isolates is associated with antimony resistance.
Ashutosh, Garg M, Sundar S, Duncan R, Nakhasi HL, Goyal N.
Antimicrob Agents Chemother. 2012 Jan;56(1):518-25. Epub 2011 Nov 7.
Discovery of safe and orally effective 4-aminoquinaldine analogues as apoptotic inducers with activity against experimental visceral leishmaniasis.
Palit P, Hazra A, Maity A, Vijayan RS, Manoharan P, Banerjee S, Mondal NB, Ghoshal N, Ali N.
Antimicrob Agents Chemother. 2012 Jan;56(1):432-45. Epub 2011 Oct 24.
Phenotypic changes in artemisinin-resistant Plasmodium falciparum lines in vitro: evidence for decreased sensitivity to dormancy and growth inhibition.
Teuscher F, Chen N, Kyle DE, Gatton ML, Cheng Q.
Antimicrob Agents Chemother. 2012 Jan;56(1):428-31. Epub 2011 Oct 10.
Absolute bioavailability of cis-mirincamycin and trans-mirincamycin in healthy rhesus monkeys and ex vivo antimalarial activity against Plasmodium falciparum.
Khemawoot P, Saunders D, Rasameesoraj M, Melendez V, Imerbsin R, Ohrt C, Fracisco S, Teja-Isavadharm P.
Antimicrob Agents Chemother. 2011 Dec;55(12):5881-6. Epub 2011 Sep 26.
Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
Rijken MJ, McGready R, Phyo AP, Lindegardh N, Tarning J, Laochan N, Than HH, Mu O, Win AK, Singhasivanon P, White N, Nosten F.
Antimicrob Agents Chemother. 2011 Dec;55(12):5500-6. Epub 2011 Sep 26.
Differential association of Plasmodium falciparum Na+/H+ exchanger polymorphism and quinine responses in field- and culture-adapted isolates of Plasmodium falciparum.
Pelleau S, Bertaux L, Briolant S, Ferdig MT, Sinou V, Pradines B, Parzy D, Jambou R.
Antimicrob Agents Chemother. 2011 Dec;55(12):5834-41. Epub 2011 Sep 26.
Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine.
Gadalla NB, Adam I, Elzaki SE, Bashir S, Mukhtar I, Oguike M, Gadalla A, Mansour F, Warhurst D, El-Sayed BB, Sutherland CJ.
Antimicrob Agents Chemother. 2011 Nov;55(11):5408-11. Epub 2011 Sep 6.
In vitro activity of antiretroviral drugs against Plasmodium falciparum.
Nsanzabana C, Rosenthal PJ.
Antimicrob Agents Chemother. 2011 Nov;55(11):5073-7. Epub 2011 Aug 29.
In vitro and in vivo studies of the utility of dimethyl and diethyl carbaporphyrin ketals in treatment of cutaneous leishmaniasis.
Taylor VM, Cedeño DL, Muñoz DL, Jones MA, Lash TD, Young AM, Constantino MH, Esposito N, Vélez ID, Robledo SM.
Antimicrob Agents Chemother. 2011 Oct;55(10):4755-64. Epub 2011 Jul 25.
Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
Marfurt J, Chalfein F, Prayoga P, Wabiser F, Kenangalem E, Piera KA, Machunter B, Tjitra E, Anstey NM, Price RN.
Antimicrob Agents Chemother. 2011 Sep;55(9):4461-4. Epub 2011 Jul 5.
CpG oligodeoxynucleotide 2006 and miltefosine, a potential combination for treatment of experimental visceral leishmaniasis.
Gupta S, Sane SA, Shakya N, Vishwakarma P, Haq W.
Antimicrob Agents Chemother. 2011 Jul;55(7):3461-4. Epub 2011 May 2.
Genomewide scan reveals amplification of mdr1 as a common denominator of resistance to mefloquine, lumefantrine, and artemisinin in Plasmodium chabaudi malaria parasites.
Borges S, Cravo P, Creasey A, Fawcett R, Modrzynska K, Rodrigues L, Martinelli A, Hunt P.
Antimicrob Agents Chemother. 2011 Oct;55(10):4858-65. Epub 2011 Jun 27.
The 8-aminoquinoline analogue sitamaquine causes oxidative stress in Leishmania donovani promastigotes by targeting succinate dehydrogenase.
Carvalho L, Luque-Ortega JR, López-Martín C, Castanys S, Rivas L, Gamarro F.
Antimicrob Agents Chemother. 2011 Sep;55(9):4204-10. Epub 2011 Jun 13.
Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria.
Djimdé AA, Tekete M, Abdulla S, Lyimo J, Bassat Q, Mandomando I, Lefèvre G, Borrmann S; B2303 Study Group.
Antimicrob Agents Chemother. 2011 Sep;55(9):3994-9. Epub 2011 Jun 13.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on